受强制性开放获取政策约束的文章 - Phil Imus了解详情
可在其他位置公开访问的文章：28 篇
Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study
TL Nickolas, KM Schmidt-Ott, P Canetta, C Forster, E Singer, M Sise, ...
Journal of the American College of Cardiology 59 (3), 246-255, 2012
强制性开放获取政策： US National Institutes of Health, German Research Foundation
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy
N Papeta, K Kiryluk, A Patel, R Sterken, N Kacak, HJ Snyder, PH Imus, ...
Journal of the American Society of Nephrology 22 (11), 1991-1996, 2011
强制性开放获取政策： US National Institutes of Health
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide
AE DeZern, ML Zahurak, HJ Symons, KR Cooke, GL Rosner, ...
Blood Advances 4 (8), 1770-1779, 2020
强制性开放获取政策： US National Institutes of Health
CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity
M Naeimi Kararoudi, Y Nagai, E Elmas, M de Souza Fernandes Pereira, ...
Blood, The Journal of the American Society of Hematology 136 (21), 2416-2427, 2020
强制性开放获取政策： US National Institutes of Health
Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide
AE DeZern, C Franklin, HL Tsai, PH Imus, KR Cooke, R Varadhan, ...
Blood advances 5 (5), 1360-1368, 2021
强制性开放获取政策： US National Institutes of Health
Severe cytokine release syndrome after haploidentical peripheral blood stem cell transplantation
PH Imus, AL Blackford, M Bettinotti, L Luznik, EJ Fuchs, CA Huff, ...
Biology of Blood and Marrow Transplantation 25 (12), 2431-2437, 2019
强制性开放获取政策： US National Institutes of Health
Major histocompatibility mismatch and donor choice for second allogeneic bone marrow transplantation
PH Imus, AL Blackford, M Bettinotti, B Iglehart, A Dietrich, N Tucker, ...
Biology of Blood and Marrow Transplantation 23 (11), 1887-1894, 2017
强制性开放获取政策： US National Institutes of Health
Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide
LK Schoch, KR Cooke, ND Wagner-Johnston, I Gojo, LJ Swinnen, P Imus, ...
Blood advances 2 (17), 2226-2229, 2018
强制性开放获取政策： US National Institutes of Health
Deep learning for diagnosis of acute promyelocytic leukemia via recognition of genomically imprinted morphologic features
JW Sidhom, IJ Siddarthan, BS Lai, A Luo, BC Hambley, J Bynum, ...
NPJ precision oncology 5 (1), 38, 2021
强制性开放获取政策： US Department of Defense
Allogeneic transplantation for Ph+ acute lymphoblastic leukemia with posttransplantation cyclophosphamide
JA Webster, L Luznik, HL Tsai, PH Imus, AE DeZern, KW Pratz, MJ Levis, ...
Blood Advances 4 (20), 5078-5088, 2020
强制性开放获取政策： US National Institutes of Health
Shortened-duration immunosuppressive therapy after nonmyeloablative, related HLA-haploidentical or unrelated peripheral blood grafts and post-transplantation cyclophosphamide
AE DeZern, H Elmariah, M Zahurak, GL Rosner, DE Gladstone, SA Ali, ...
Biology of blood and marrow transplantation 26 (11), 2075-2081, 2020
强制性开放获取政策： US National Institutes of Health
Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70
PH Imus, HL Tsai, L Luznik, EJ Fuchs, CA Huff, DE Gladstone, P Lowery, ...
Blood advances 3 (17), 2608-2616, 2019
强制性开放获取政策： US National Institutes of Health
Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis with nonmyeloablative conditioning for blood or marrow transplantation for myelofibrosis
T Jain, HL Tsai, AE DeZern, LP Gondek, H Elmariah, J Bolaños-Meade, ...
Transplantation and cellular therapy 28 (5), 259. e1-259. e11, 2022
强制性开放获取政策： US National Institutes of Health
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma
RS Greenberg, JA Ruddy, BJ Boyarsky, WA Werbel, JM Garonzik-Wang, ...
BMC cancer 21, 1-5, 2021
强制性开放获取政策： US National Institutes of Health
Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): a trial of the ECOG-ACRIN cancer research group …
LJ Swinnen, A O’Neill, PH Imus, S Gujar, D Schiff, LR Kleinberg, ...
Oncotarget 9 (1), 766, 2018
强制性开放获取政策： US National Institutes of Health
An allogeneic multiple myeloma GM-CSF–secreting vaccine with lenalidomide induces long-term immunity and durable clinical responses in patients in near complete remission
L Biavati, CA Huff, A Ferguson, A Sidorski, MA Stevens, L Rudraraju, ...
Clinical Cancer Research 27 (24), 6696-6708, 2021
强制性开放获取政策： US National Institutes of Health
Thrombotic microangiopathy after post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis
PH Imus, HL Tsai, AE DeZern, K Jerde, LJ Swinnen, J Bolaños-Meade, ...
Biology of Blood and Marrow Transplantation 26 (12), 2306-2310, 2020
强制性开放获取政策： US National Institutes of Health
Allogeneic blood or marrow transplantation with post-transplantation cyclophosphamide for peripheral T cell lymphoma: the importance of graft source
CH Sterling, MS Hughes, HL Tsai, K Yarkony, EJ Fuchs, LJ Swinnen, ...
Transplantation and cellular therapy 29 (4), 267. e1-267. e5, 2023
强制性开放获取政策： US National Institutes of Health
Nonmyeloablative, HLA-mismatched unrelated peripheral blood transplantation with high-dose post-transplantation cyclophosphamide
KC Rappazzo, M Zahurak, M Bettinotti, SA Ali, AJ Ambinder, ...
Transplantation and cellular therapy 27 (11), 909. e1-909. e6, 2021
强制性开放获取政策： US National Institutes of Health
A Study of Physical Resilience and Aging (SPRING): conceptual framework, rationale, and study design
J Walston, R Varadhan, QL Xue, B Buta, F Sieber, J Oni, P Imus, ...
Journal of the American Geriatrics Society 71 (8), 2393-2405, 2023
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定